Israel Englander’s AtriCure ATRC Stock Holding History

Israel Englander’s Portfolio ATRC Stock Details ATRC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-60,000	Closed	-$1.83M	–	5863
2024 Q1	$1.83M	Sell	60,000 -10,000	-14%	-$335K	﹤0.01%	3828
2023 Q4	$2.5M	Buy	+70,000	New	+$2.6M	﹤0.01%	3421
2023 Q1	–	Sell	-30,000	Closed	-$1.33M	–	6348
2022 Q4	$1.33M	Buy	+30,000	New	+$1.25M	﹤0.01%	3892
2021 Q4	–	Sell	-10,000	Closed	-$696K	–	6759
2021 Q3	$696K	Hold	10,000	–	–	﹤0.01%	5024
2021 Q2	$793K	Hold	10,000	–	–	﹤0.01%	4889
2021 Q1	$655K	Sell	10,000 -5,000	-33%	-$308K	﹤0.01%	4596
2020 Q4	$835K	Buy	+15,000	New	+$649K	﹤0.01%	3848
2020 Q3	–	Sell	-5,000	Closed	-$225K	–	4427
2020 Q2	$225K	Buy	+5,000	New	+$218K	﹤0.01%	3795
2019 Q2	–	Sell	-20,000	Closed	-$536K	–	4036
2019 Q1	$536K	Buy	+20,000	New	+$607K	﹤0.01%	3220
2018 Q1	–	Sell	-20,000	Closed	-$365K	–	3617
2017 Q4	$365K	Buy	+20,000	New	+$396K	﹤0.01%	3246

Other funds holding ATRC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

HRCM

Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

California State Teachers Retirement System (CalSTRS) West Sacramento, California $782B AUM 28.39% 1-Year Est. Return

NAMI

Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Israel Englander's ATRC Position: Q2 2026 in Review

Israel Englander sold out of AtriCure (ATRC) in Q2 2026, closing a stake of 179,886 shares — an estimated $5.13M sold.

Israel Englander first reported a position in ATRC in Q3 2013 and held it in 48 quarters. The position peaked at $68.8M in Q4 2021. 251 funds tracked by Wall St. Rank hold ATRC as of Q2 2026.

Israel Englander reported no remaining AtriCure position as of Q2 2026 after selling out during the quarter.
Israel Englander sold 179,886 AtriCure shares in Q2 2026, an estimated $5.13M.
Israel Englander first reported a position in AtriCure in Q3 2013 and held it in 48 quarters.
Israel Englander's AtriCure position peaked at $68.8M in Q4 2021.
251 funds tracked by Wall St. Rank held AtriCure as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.